IDO, produced mainly by immune cells recruited by the tumor, particularly DCs (72) is a key enzyme in tryptophan metabolism involved in immune tolerance and immunosuppression in cancer, as it can induce T cell anergy and Treg expansion (73, 74). Here, IDO1 is linked to neoplasm.